Close to the Bone: Tissue-Specific Checkpoint Immunotherapy Evasion.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31730845.
- Also identified by DOI 10.1016/j.cell.2019.10.022.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Primary or secondary resistance to immune checkpoint therapy is often analyzed in primary tumors rather than metastases. In this issue of Cell, Jiao et al. show that the site of metastatic diffusion matters and bones empower a particularly hostile environment.
Medical subject headings
- Neoplasms
- Tumor Microenvironment